硼替佐米杂质E
|
|
|
- CAS号:
- 1132709-14-8
- 英文名:
- ((S)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid
- 英文别名:
- 2S)-Bortezomib;(1S,2S)-BortezoMib;Bortezomib (1S, 2S);Bortizomib SS-isomer;Bortezomib S,S Isomer;Bortezomib Impurity PS619;Bortezomib USP Impurity G;Bortezomib (1S,2S) isomer;(1S,2S)-Bortezomib Impurity;Bortezomib Diastereomer (S,S)
- 中文名:
- 硼替佐米杂质E
- 中文别名:
- S,S-异构体;硼替佐米杂质E;硼替佐米杂质G0;硼替佐米杂质03;3硼替佐米杂质G;硼替佐米杂质 19;化合物 T10061;硼替佐米杂质PS619;硼替佐米(1S,2S);(1S,2S)-硼替佐米
- CBNumber:
- CB12661930
- 分子式:
- C19H25BN4O4
- 分子量:
- 384.24
- MOL File:
- 1132709-14-8.mol
|
|
|
硼替佐米杂质E化学性质
-
密度:
-
1.214±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO : 50 mg/mL (130.13 mM; Need ultrasonic)
-
|
-
形态:
-
Solid
-
|
-
酸度系数(pKa):
-
9.66±0.43(Predicted)
-
|
-
颜色:
-
White to Off-White
-
|
-
稳定性:
-
Hygroscopic
-
|
硼替佐米杂质E性质、用途与生产工艺
(1S,2S)-Bortezomib 是 Bortezomib 的对映异构体。Bortezomib 是一种细胞渗透性、可逆性和选择性的蛋白酶体抑制剂，通过靶向苏氨酸残基有效抑制 20S 蛋白酶体 (Ki 为 0.6 nM)。Bortezomib 破坏细胞周期、诱导细胞凋亡以及抑制核因子 NF-κB。Bortezomib 是一种抗癌药物，也是第一种用于人类的蛋白酶体抑制剂。
Ki: 0.6 nM (20S proteasome)
用途
(1S,2S)-Bortezomib is an isomer of Bortezomib (B675700), proteasome inhibitor. (1S,2S)-Bortezomib has been seen to inhibit serine proteases shown to lower cellular Aβ concentrations, associated with A
lzheimer鈥檚 or hypertension.
硼替佐米杂质E
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/01/25 | HY-135396 | 硼替佐米杂质E
(1S,2S)-Bortezomib | 1132709-14-8 | 1mg | 1200元 |
| 2024/01/25 | HY-135396 | 硼替佐米杂质E
(1S,2S)-Bortezomib | 1132709-14-8 | 5mg | 3500元 |
1132709-14-8, 硼替佐米杂质E 相关搜索:
硼替佐米杂质1(R,S-异构体) 硼替佐米杂质2(RR异构体) 硼替佐米杂质K 硼替佐米杂质 硼替佐米杂质K 硼替佐米杂质2(SR异构体,EP杂质E) 硼替佐米杂质M 硼替佐米 硼替佐米杂质-异构体 硼替佐米中间体2 (aR,3aS,4S,6S,7aR)-六氢-3a,8,8-三甲基-alpha-(2-甲基丙基)-4,6-甲桥-1,3,2-苯并二氧硼烷-2-甲胺2,2,2-三氟乙酸盐 硼替佐米杂质L 雌激素受体抗体(单抗) α－法呢烯 雌四醇 硼替佐米杂质 保特佐米蒎烷二醇酯 硼替佐米杂质2((1S,2R)-异构体和(1R,2R)-异构体的混合物)
- Chiral Reagents, Boron Derivatives, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals
- 抑制剂
- 163-硼替佐米
- 标准品
- 杂质对照品
- 对照品-杂质对照品
- 硼替佐米杂质G以及硼替佐米全套
- 化合物 T10061
- 3硼替佐米杂质G
- 硼替佐米杂质03
- 硼替佐米杂质G0
- (1S,2S)-硼替佐米
- (1S)-3-甲基-1-[[(2S)-1- 氧代-3-苯基-2-[(吡嗪甲酰基)-氨基]丙基] 氨基]丁基] 硼酸
- 硼替佐米(1S,2S)异构体
- 硼替佐米(1S,2S)
- 硼替佐米杂质1(S,S-异构体)
- 硼替佐米杂质PS619
- 硼替佐米杂质E
- 硼替佐米杂质 19
- (1S,2S)-硼替佐米杂质
- BORTEZOMIB杂质 E
- S,S-异构体
- 1132709-14-8
- Bortezomib S,S Isomer
- ((S)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxaMido)prop
- 2S)-Bortezomib
- ((R)-3-hydroxy-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid
- Bortezomib Diastereomer (S,S)
- Bortezomib Related Compound G (Bortezomib S,S-Isomer Impurity)
- Bortizomib SS-isomer
- (1s) - 3-methyl-1 - [[(2S) - 1-oxo-3-phenyl-2 - [(pyrazinoformyl) - amino] propyl] amino] butyl] boric acid
- Bortezomib (1S,2S) isomer
- Bortezomib (1S, 2S)
- Bortezomib impurity 3/(1S,2S)-Bortezomib
- [(1S)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
- Bortezomib USP Impurity G
- Bortezomib (1S,2S) Isomer Impurity
- Bortezomib Impurity PS619
- [(1S)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2[(pyrazinylcarbonyl) amino]propyl]amino]butyl] boronic acid
- (1S,2S)-Bortezomib Impurity
- N-(2-Pyrazinecarbonyl)-L-phenylalanine-D-leucine boronic anhydride
- (1S,2S)-BortezoMib
- Boronic acid, B-[(1S)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)aMino]propyl]aMino]butyl]-
- ((S)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid